RSS-Feed abonnieren

DOI: 10.1055/s-0042-1756431
Effect of Comorbidities on the Outcome of Patients with Aneurysmal Subarachnoid Hemorrhage: A Prospective Observational Study

Abstract
Background The pathophysiological changes following aneurysmal subarachnoid hemorrhage (aSAH) lead to a varied degree of neurological deficit and cognitive decline. The presence of comorbidities can contribute to the progression and course of the disease resulting in high morbidity and mortality.
Methods A total of 140 patients with aSAH, scheduled for surgical clipping or endovascular coiling were included. The patients' comorbidities were recorded. The postoperative outcome was evaluated using Glasgow Outcome Scale at 1 month following discharge. Multiple logistic regression analysis was performed to identify variables predicting poor outcome, taking into consideration those variables which were significant in univariate analysis.
Results Sixty-six percent of these patients with aSAH had associated comorbidities. In our patient cohort, we found that smoking and hypertension were associated with worse outcome (odds ratio [OR] = 4.63 [confidence interval [CI] = 1.83–11.7] and OR = 2.92 [CI = 1.41–6.01], respectively). Hypothyroidism, diabetes mellitus, coronary artery disease, and asthma did not influence the neurological outcome because of their small number.
Conclusion Presence of comorbidities like smoking and hypertension significantly worsen the outcome of these patients with aSAH.
Keywords
aneurysmal subarachnoid hemorrhage - comorbidities - hypertension - smoking - Glasgow Outcome ScalePublikationsverlauf
Artikel online veröffentlicht:
09. Dezember 2022
© 2022. Indian Society of Neuroanaesthesiology and Critical Care. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Etminan N, Chang HS, Hackenberg K. et al. Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population: a systematic review and meta-analysis. JAMA Neurol 2019; 76 (05) 588-597
- 2 Kapoor K, Kak VK. Incidence of intracranial aneurysms in north-west Indian population. Neurol India 2003; 51 (01) 22-26
- 3 Avdagic SS, Brkic H, Avdagic H, Smajic J, Hodzic S. Impact of comorbidity on early outcome of patients with subarachnoid hemorrhage caused by cerebral aneurysm rupture. Med Arh 2015; 69 (05) 280-283
- 4 Dasenbrock HH, Rudy RF, Rosalind Lai PM. et al. Cigarette smoking and outcomes after aneurysmal subarachnoid hemorrhage: a nationwide analysis. J Neurosurg 2018; 129 (02) 446-457
- 5 Lindgren AE, Kurki MI, Riihinen A. et al. Type 2 diabetes and risk of rupture of saccular intracranial aneurysm in eastern Finland. Diabetes Care 2013; 36 (07) 2020-2026
- 6 Bhardwaj A, Bhagat H, Grover VK. et al. Comparison of propofol and desflurane for postanaesthetic morbidity in patients undergoing surgery for aneurysmal SAH: a randomized clinical trial. J Anesth 2018; 32 (02) 250-258
- 7 Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975; 1 (7905): 480-484
- 8 Sodhi HB, Savardekar AR, Mohindra S, Chhabra R, Gupta V, Gupta SK. The clinical profile, management, and overall outcome of aneurysmal subarachnoid hemorrhage at the neurosurgical unit of a tertiary care center in India. J Neurosci Rural Pract 2014; 5 (02) 118-126
- 9 Suarez JI, Tarr RW, Selman WR. Aneurysmal subarachnoid hemorrhage. N Engl J Med 2006; 354 (04) 387-396
- 10 Jaja BNR, Lingsma H, Schweizer TA, Thorpe KE, Steyerberg EW, Macdonald RL. SAHIT collaboration. Prognostic value of premorbid hypertension and neurological status in aneurysmal subarachnoid hemorrhage: pooled analyses of individual patient data in the SAHIT repository. J Neurosurg 2015; 122 (03) 644-652
- 11 Juvela S. Prehemorrhage risk factors for fatal intracranial aneurysm rupture. Stroke 2003; 34 (08) 1852-1857
- 12 Juvela S, Siironen J, Kuhmonen J. Hyperglycemia, excess weight, and history of hypertension as risk factors for poor outcome and cerebral infarction after aneurysmal subarachnoid hemorrhage. J Neurosurg 2005; 102 (06) 998-1003
- 13 Kim J, Kim JH, Lee HS, Suh SH, Lee KY. Association between longitudinal blood pressure and prognosis after treatment of cerebral aneurysm: a nationwide population-based cohort study. PLoS One 2021; 16 (05) e0252042
- 14 Hammer A, Steiner A, Ranaie G. et al. Impact of comorbidities and smoking on the outcome in aneurysmal subarachnoid hemorrhage. Sci Rep 2018; 8 (01) 12335
- 15 Modesti PA, Reboldi G, Cappuccio FP. et al; ESH Working Group on CV Risk in Low Resource Settings. Panethnic differences in blood pressure in Europe: a systematic review and meta-analysis. PLoS One 2016; 11 (01) e0147601
- 16 Grundy SM, Stone NJ, Bailey AL. et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2019; 73 (24) 3168-3209
- 17 Rinkel GJ, Prins NE, Algra A. Outcome of aneurysmal subarachnoid hemorrhage in patients on anticoagulant treatment. Stroke 1997; 28 (01) 6-9
- 18 Lindbohm JV, Kaprio J, Jousilahti P, Salomaa V, Korja M. Risk factors of sudden death from subarachnoid hemorrhage. Stroke 2017; 48 (09) 2399-2404
- 19 Gaetani P, Tartara F, Tancioni F, Klersy C, Forlino A, Baena RR. Activity of α 1-antitrypsin and cigarette smoking in subarachnoid haemorrhage from ruptured aneurysm. J Neurol Sci 1996; 141 (1-2): 33-38
- 20 Carandang RA, Barton B, Rordorf GA, Ogilvy CS, Sims JR. Nicotine replacement therapy after subarachnoid hemorrhage is not associated with increased vasospasm. Stroke 2011; 42 (11) 3080-3086
- 21 Krishna V, Kim DH. Ethnic differences in risk factors for subarachnoid hemorrhage. J Neurosurg 2007; 107 (03) 522-529
- 22 Feigin VL, Rinkel GJ, Lawes CM. et al. Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke 2005; 36 (12) 2773-2780
- 23 International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms–risk of rupture and risks of surgical intervention. N Engl J Med 1998; 339 (24) 1725-1733
- 24 Ragni MV, Lewis JH, Spero JA, Hasiba U. Bleeding and coagulation abnormalities in alcoholic cirrhotic liver disease. Alcohol Clin Exp Res 1982; 6 (02) 267-274
- 25 Juvela S. Alcohol consumption as a risk factor for poor outcome after aneurysmal subarachnoid haemorrhage. BMJ 1992; 304 (6843): 1663-1667
- 26 Kruyt ND, Biessels GJ, de Haan RJ. et al. Hyperglycemia and clinical outcome in aneurysmal subarachnoid hemorrhage: a meta-analysis. Stroke 2009; 40 (06) e424-e430
- 27 Suarez JI. Does hyperglycemia contribute to secondary injury in subarachnoid hemorrhage?. Stroke 2006; 37 (01) 8-9
- 28 Kamada H, Yu F, Nito C, Chan PH. Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia/reperfusion in rats: relation to blood-brain barrier dysfunction. Stroke 2007; 38 (03) 1044-1049
- 29 Kruyt ND, Biessels GJ, DeVries JH. et al. Hyperglycemia in aneurysmal subarachnoid hemorrhage: a potentially modifiable risk factor for poor outcome. J Cereb Blood Flow Metab 2010; 30 (09) 1577-1587
- 30 Song EC, Chu K, Jeong SW. et al. Hyperglycemia exacerbates brain edema and perihematomal cell death after intracerebral hemorrhage. Stroke 2003; 34 (09) 2215-2220
- 31 Atchaneeyasakul K, Tipirneni A, Zhang T. et al. Association of hypothyroidism with unruptured cerebral aneurysms: a case-control study. J Neurosurg 2018; 128 (02) 511-514